ALEXION PHARMACEUTICALS
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the discovery, development and commercialization of life-changing therapies. Alexion Canada began operations in 2009 and partners with all stakeholders, including health-care providers, patient advocacy organizations and governments to best serve patients. By expanding the knowledge and awareness of rare diseases, we help the medical community improve the diagnosis and the management of these diseases.
LEARN MORE:
Website: https://alexion.com/
Twitter: @AlexionPharma
LinkedIn: @Alexion Pharmaceuticals, Inc.
YouTube: Alexion Pharmaceuticals, Inc.
CONTACT INFORMATION:
Brad McCaw
Associate Director, Market Access
Alexion Pharmaceuticals, Inc.
1-519-636-9784
bradley.mccaw@alexion.com
DOWNLOAD PDF RESOURCE
BRISTOL MYERS SQUIBB
At Bristol Myers Squibb, we work every day to help patients. Patients are at the center of everything we do. They inspire us. They are the reason we come to work each day. We aspire to be at the center of a vibrant healthcare ecosystem, where academic research centers, biotech and biopharma companies all contribute to continued scientific advancement.
LEARN MORE:
Website: bms.com/ca
DOWNLOAD PDF RESOURCE
HEALTH SOLUTIONS BY SHOPPERS
High-value services from a name Canadians trust
Established in 2010, Health Solutions by Shoppers works collaboratively with Canada’s leading employers, insurance companies, and benefits advisors to drive innovation in benefits plan management and employee wellness.
Leveraging Shoppers Drug Mart and Loblaw’s strong industry partnerships, drug expertise, and unmatched retail assets, the Health Solutions by Shoppers team is committed to enabling
employers to provide their employees with drug plan and health management solutions that are affordable and sustainable.
LEARN MORE:
morewaystobenefit.ca
DOWNLOAD PDF RESOURCE
INNOVATIVE MEDICINES CANADA
Innovative Medicines Canada is the national voice of Canada’s innovative pharmaceutical industry. We advocate for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. We support our members’ commitment to being valued partners in the Canadian health-care system.
LEARN MORE:
Website: http://innovativemedicines.ca/
Facebook: @Innovativemeds
Twitter: @innovativemeds
LinkedIn: @Innovative Medicines Canada
CONTACT INFORMATION:
Joe Farago
Executive Director, Private Payers and Investment
Innovative Medicines Canada
1-613-236-0455 x212
jfarago@imc-mnc.ca
MEDAVIE BLUE CROSS
Medavie Blue Cross is a premier all-in-one carrier that provides health, dental, travel, life and disability benefits and administers federal and provincial government-sponsored health programs. Together with Medavie Health Services, we are part of Medavie, a health solutions partner committed to improving the wellbeing of Canadians.
We are one of Canada's Most Admired Corporate Cultures and Canada’s Life & Health Insurer of the Year for 2021. As a not-for-profit organization, we don’t have shareholders. Instead, we proudly invest in communities to help address some of Canada’s most pressing health care challenges.
LEARN MORE:
Website: https://www.medaviebc.ca/
Twitter: @MedavieBC
LinkedIn: Medavie Blue Cross
Facebook: Medavie Blue Cross
CONTACT INFORMATION:
Katrina White, senior marketing advisor
(416) 695-5870
katrina.white@medavie.bluecross.ca
DOWNLOAD PDF RESOURCE
NOVO NORDISK CANADA
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark.
Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity, and rare blood and rare endocrine diseases.
We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.
LEARN MORE:
Website: novonordisk.ca
Twitter: @NovoNordiskCA
LinkedIn: www.linkedin.com/company/novo-nordisk/
CONTACT INFORMATION:
Kanza Manzoor, Senior manager, Patient Access
knmq@novonordisk.com
DOWNLOAD ENGLISH PDF RESOURCE
DOWNLOAD FRENCH PDF RESOURCE
SUN LIFE
Sun Life is a leading international financial services organization providing asset management, wealth, insurance and health solutions to individual and institutional Clients. Sun Life has operations in a number of markets worldwide, including Canada, the United States, the United Kingdom, Ireland, Hong Kong, the Philippines, Japan, Indonesia, India, China, Australia, Singapore, Vietnam, Malaysia and Bermuda. As of June 30, 2022, Sun Life had total assets under management of $1.26 trillion.
Sun Life Financial Inc. trades on the Toronto (TSX), New York (NYSE) and Philippine (PSE) stock exchanges under the ticker symbol SLF.
LEARN MORE:
Website: www.sunlife.com
Facebook: @SLFCanada
Twitter: @SunLifeCA
LinkedIn: @Sun Life
Instagram: @sunlifeca
DOWNLOAD PDF RESOURCE
TAKEDA CANADA
Takeda Canada is one of the fastest-growing pharmaceutical companies in Canada delivering better health for Canadians through leading innovations in gastroenterology, oncology, neuroscience, and rare diseases. Takeda’s top priority is the health of Canadians; their well-being is central to our work and drives our commitment to deliver a diverse portfolio of innovative treatments in specialty care.
Guided by an unwavering commitment to significantly improve lives and in collaboration with key stakeholders, we are committed to providing needed services and solutions beyond our medicines. Our core values are deeply ingrained in our culture and in the way we conduct our business. Led by the top talent in the industry, Takeda strives to become a best-in-class specialty care provider focusing in the areas we work to serve the needs of Canadian patients.
LEARN MORE:
www.takeda.com/en-ca
DOWNLOAD PDF RESOURCE
TELUS HEALTH
TELUS Health is a global healthcare company serving people in more than 160 countries delivering both digital innovation and clinical services to improve total physical, mental and financial health and wellness across the full spectrum of primary and preventative care. By leveraging the power of technology to deliver connected solutions and services both in-person and virtually, TELUS Health is improving access to care and revolutionizing the flow of information while facilitating collaboration, efficiency, and productivity for physicians, pharmacists, health authorities, allied healthcare professionals, insurers, employers and people globally, progressing its vision of transforming healthcare and empowering people to live healthier lives.
VERTEX
Vertex is a global biotechnology company that invests in scientific innovation to create medicines for people with serious diseases. The company has multiple cystic fibrosis (CF) medicines in the market, and several ongoing clinical and research programs in CF. Beyond CF, Vertex has a robust pipeline of investigational small molecule medicines in other serious diseases where it has deep insight into causal human biology, including pain, alpha-1 antitrypsin deficiency, and APOL1-mediated kidney disease. In addition, Vertex has a rapidly expanding pipeline of genetic and cell therapies for diseases such as sickle cell disease, beta thalassemia, Duchenne muscular dystrophy and type 1 diabetes mellitus.
Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London, UK. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia and Latin America. Vertex is consistently recognized as one of the industry's top places to work, including 11 consecutive years on Science magazine's Top Employers list and a best place to work for LGBTQ equality by the Human Rights Campaign.
LEARN MORE:
www.vrtx.ca
DOWNLOAD PDF RESOURCE
GSK
GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years. Our bold ambitions for patients are reflected in new commitments to growth and a step-change in performance.
We prioritize innovation in vaccines and specialty medicines, maximizing the increasing opportunities to prevent and treat infectious diseases by focusing on four therapeutic areas: HIV, oncology, and immunology including respiratory diseases. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development.
GSK has a history in Canada that dates back to 1902. We have two divisional headquarters in Mississauga, Ontario and Montréal, Québec, and one vaccine manufacturing facility located in Sainte-Foy, Québec.
LEARN MORE:
Website: www.GSK.ca
Twitter: twitter.com/GSKca
LinkedIn: https://www.linkedin.com/company/gsk/
DOWNLOAD PDF RESOURCE
MERCK
For over a century, Merck has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, Merck continues to be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.
LEARN MORE:
Website: www.merck.ca
Youtube: @MerckCanada
Twitter: @MerckCanada
CONTACT INFORMATION:
Jeff Ellis, associate director, patient access
jeffrey.ellis@merck.com
DOWNLOAD PDF RESOURCE
PFIZER CANADA
Pfizer Canada ULC is the Canadian operation of Pfizer Inc., one of the world's leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world’s best known and most prescribed medicines and vaccines. Pfizer’s ongoing research and development activities focus on a wide range of therapeutic areas following our guiding purpose: Breakthroughs that change patients’ livesTM.
LEARN MORE:
Website: pfizer.ca
LinkedIn: www.linkedin.com/company/pfizer/
Facebook: www.facebook.com/Pfizer.Canada/
Twitter: www.twitter.com/PfizerCA
Youtube: Pfizer Canada
CONTACT INFORMATION:
Jenev Portelance, senior manager, private sector access
Jenev.Portelance@pfizer.com
DOWNLOAD PDF RESOURCE